Search

everythinglearnresearchcommunity

for

Search:↓

New information suggests that metformin might help more women with PCOS and infertility, not just those with glucose issues.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Metformin combined with dyne-35 increases ovulation and pregnancy rates in PCOS patients.

Dienogest is safer and has fewer side effects than GnRH analogues for treating endometriosis.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Lower baseline prolactin levels may lead to better insulin resistance improvement with metformin in PCOS patients.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Neurokinin B levels are higher in the placentas of women with PCOS who have female babies.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Medroxyprogesterone acetate is as effective as oral contraceptives for resuming ovulation in women with PCOS.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Platelet-rich plasma may improve embryo genetics in IVF.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.